ArticleThe veterinary quarterly2025
Prevalence and characteristics of transient myocardial thickening in cats with hypertrophic cardiomyopathy phenotypes.
Article in The veterinary quarterly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- First Description of Hypertrophic Cardiomyopathy Phenotype in Apparently Healthy Cats in Morocco: An Echocardiographic Prevalence Study.Animals : an open access journal from MDPI · 2026Article
- Presumed acute myocardial damage in a British Shorthair cat with previously diagnosed hypertrophic cardiomyopathy.Irish veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to propose new diagnostic criteria and provide detailed descriptions of cats diagnosed with transient myocardial thickening (TMT) using a retrospective design. HCM phenotype cases were defined as cats with echocardiographic findings of a maximum left ventricular wall thickness (LVWT) ≥6 mm on at least one presentation. TMT was defined as an increased LVWT ≥6 mm on at least two presentations, a subsequent decrease in LVWT of more than 25% within 6 months, no subsequent increase in left atrial-to-aortic root ratio (LA/Ao) ≥20% from baseline, and a fractional shortening ≤30%. A total of 145 cats had HCM phenotypes. Among cats that underwent serial echocardiography (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.